These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 35307646)

  • 21. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma.
    Zhang L; Jiang G; Lu J; Wang L
    Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
    Zhao W; Yang S; Chen J; Zhao J; Dong J
    Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
    Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma.
    Xue W; Dong B; Zhao Y; Wang Y; Yang C; Xie Y; Niu Z; Zhu C
    Cell Oncol (Dordr); 2021 Dec; 44(6):1351-1361. PubMed ID: 34796468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination.
    Zhang C; Wang Y; Wu G; Sun N; Bai H; Li X; Han S; Zhou H; Qi R; Zhang J
    Biol Direct; 2024 Feb; 19(1):16. PubMed ID: 38395908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT.
    Zhang Y; Ji G; Han S; Shao Z; Lu Z; Huo L; Zhang J; Yang R; Feng Q; Shen H; Wang H; Li X
    Cell Physiol Biochem; 2018; 50(2):612-628. PubMed ID: 30308494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcyclin-binding protein contributes to cholangiocarcinoma progression by inhibiting ubiquitination of MCM2.
    Zhang Y; Liu L; Luo B; Tang H; Yu X; Bao S
    Oncol Res; 2023; 31(3):317-331. PubMed ID: 37305391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling.
    Zeng C; Lin J; Zhang K; Ou H; Shen K; Liu Q; Wei Z; Dong X; Zeng X; Zeng L; Wang W; Yao J
    Cancer Sci; 2022 Nov; 113(11):3766-3775. PubMed ID: 35968603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma.
    Tan XY; Chang S; Liu W; Tang HH
    Gut Liver; 2014 Mar; 8(2):196-204. PubMed ID: 24672662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. lncRNA SNHG16 Mediates Cell Proliferation and Apoptosis in Cholangiocarcinoma by Directly Targeting miR-146a-5p/GATA6 Axis.
    Wu T; Lei MS; Gao XZ; Xiong TG; Yang K; Gong Q; Tang R; Tian YP; Fu XH
    Biochem Genet; 2021 Oct; 59(5):1311-1325. PubMed ID: 33797690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
    Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
    Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photodynamic therapy inhibits cancer progression and induces ferroptosis and apoptosis by targeting P53/GPX4/SLC7A11 signaling pathways in cholangiocarcinoma.
    Yan X; Li Z; Chen H; Yang F; Tian Q; Zhang Y
    Photodiagnosis Photodyn Ther; 2024 Jun; 47():104104. PubMed ID: 38679154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the PI3K-AKT signaling pathway by SPARC contributes to the malignant phenotype of cholangiocarcinoma cells.
    Deng S; Zhang L; Li J; Jin Y; Wang J
    Tissue Cell; 2022 Jun; 76():101756. PubMed ID: 35217388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Mir-122 on Human Cholangiocarcinoma Proliferation, Invasion, and Apoptosis Through P53 Expression.
    Wu C; Zhang J; Cao X; Yang Q; Xia D
    Med Sci Monit; 2016 Jul; 22():2685-90. PubMed ID: 27472451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CircSETD3 (hsa_circ_0000567) inhibits proliferation and induces apoptosis in cholangiocarcinoma cells via downregulation of microRNA-421 expression.
    Xiong W; Zhang A; Xiao X; Liu W
    Bioengineered; 2022 Apr; 13(4):10191-10201. PubMed ID: 35435120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis.
    Du H; Hou S; Zhang L; Liu C; Yu T; Zhang W
    Aging (Albany NY); 2023 May; 15(9):3759-3770. PubMed ID: 37166421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PLAU contributes to the development of cholangiocarcinoma via activating NF-κB signaling pathway.
    Hu MD; Jia LH; Wang ML
    Cell Biol Int; 2023 Aug; 47(8):1381-1391. PubMed ID: 37067236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
    Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
    Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.
    Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C
    Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.